A total of 72, blood donations were evaluated. Reproducibility panels were evaluated at three testing sites across three lots. Clinical specificity in pools was There was one HBV yield case.
|Country:||Sao Tome and Principe|
|Published (Last):||17 May 2017|
|PDF File Size:||13.31 Mb|
|ePub File Size:||16.91 Mb|
|Price:||Free* [*Free Regsitration Required]|
Search: Search. Advanced Clipboard. Create file Cancel. Email citation To:. Format: Summary Summary text Abstract Abstract text. Send email Cancel.
Add to Collections Create a new collection Add to an existing collection. Name your collection: Name must be less than characters. Choose a collection: Unable to load your collection due to an error Please try again. Add Cancel. Add to My Bibliography My Bibliography. Unable to load your delegates due to an error Please try again.
Your saved search Name of saved search:. Search terms:. Test search terms. Would you like email updates of new search results?
Email: change. Frequency: Monthly Weekly Daily. Which day? Send at most: 1 item 5 items 10 items 20 items 50 items items items. Send even when there aren't any new results. Optional text in email:. Save Cancel. Create a file for external citation management software Create file Cancel. Full-text links Cite Favorites.
Similar articles Evaluation of the Roche cobas s system and cobas TaqScreen multiplex test for blood screening: a European multicenter study. Jarvis L, et al. Epub May Wiedmann M, et al. J Clin Virol. Epub Jul 5. PMID: Koppelman MH, et al. Vox Sang. Busch MP. Transfus Clin Biol. PMID: Review. Suzuki F. Rinsho Byori. Show more similar articles See all similar articles. Cited by 1 article Hierarchical group testing for multiple infections.
Hou P, et al. Epub Sep Publication types Evaluation Study Actions. Humans Actions. Reproducibility of Results Actions.
Sensitivity and Specificity Actions. United States Actions. RNA, Viral Actions. Reagent Kits, Diagnostic Actions. Full-text links [x] Elsevier Science. Copy Download.
U.S. Food and Drug Administration
Plasma from all donors may be screened as individual specimens. For donations of whole blood and blood components, plasma specimens may be tested individually or in pools comprised of aliquots of individual specimens in conjunction with serology tests for HIV, HCV and HBV. For donations of whole blood and blood components, plasma specimens may be tested individually or in pools comprised of not more than 6 individual specimens. For donations of source plasma, sample may be tested in pools comprised of not more than 96 individual specimens.